YK-5-252

N/A

Report date: 2024/12/03 10:25:35
NME

Base Information

Drug NameYK-5-252
Drug Alias NameYK-5-252
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin modulators
TargetsTubulin
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInova Center for Personalized Health
China Registration ClassN/A

Develop Information

Active CompaniesInova Center for Personalized Health
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A